Hemostasis Products Market Size

  • Report ID: 4447
  • Published Date: Jul 29, 2024
  • Report Format: PDF, PPT

Hemostasis Products Market Size

Hemostasis Products Market ssize was over USD 1.73 Billion in 2023 and is expected to reach USD 3.31 Billion by the end of 2036, growing at around 5.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of hemostasis products is assessed at USD 1.81 Billion. The growth of the market can be attributed primarily to the rising prevalence of cardiovascular diseases worldwide, owing to adoption of unhealthy lifestyle, consumption of unhealthy food products and rising illnesses among the population. According to the World Health Organization, in 2019, 17.9 million people died from cardiovascular diseases, representing 32% of all deaths worldwide. Heart attacks and strokes accounted for 85% of these deaths.

To promote wound healing, hemostasis prevents or slows down blood flow or clotting following injury. Hemostatic products that are based on tissue are widely used to pack wounds after a severe injury. Furthermore, the rising medical tourism, higher investments by government in development of hemostasis products, huge base of geriatric population coupled with large number of blood disorders patient population are expected to drive global hemostasis products market growth during the forecast period.


Hemostasis Products Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4447
  • Published Date: Jul 29, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of hemostasis products is assessed at USD 1.81 Billion.

The hemostasis products market size was over USD 1.73 Billion in 2023 and is expected to reach USD 3.31 Billion by the end of 2036, growing at around 5.1% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of cardiovascular diseases, huge base of geriatric population along with increasing blood clotting disorders are the major factors driving the market growth.

North America is set to hold majority industry share of 31% by 2036, owing to rising incidence of heart diseases such as heart attacks and heart strokes along with rising geriatric population in the region.

Terumo Corporation, Baxter International, Inc., Sysmex Asia Pacific Pte Ltd, Abbott Healthcare Private Limited, csl behring llc, Grifols, S.A., Dexur Inc, Pfizer Inc., Tricol Biomedical., Medtronic plc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample